Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Net Income (2020 - 2025)

Historic Net Income for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$18.7 million.

  • SOPHiA GENETICS's Net Income fell 307.51% to -$18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$71.2 million, marking a year-over-year decrease of 140.07%. This contributed to the annual value of -$62.5 million for FY2024, which is 2087.59% up from last year.
  • SOPHiA GENETICS's Net Income amounted to -$18.7 million in Q3 2025, which was down 307.51% from -$20.9 million recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's Net Income peaked at -$12.3 million during Q1 2021, and registered a low of -$25.0 million during Q1 2022.
  • Moreover, its 5-year median value for Net Income was -$18.7 million (2025), whereas its average is -$18.8 million.
  • Its Net Income has fluctuated over the past 5 years, first skyrocketed by 9980.63% in 2021, then plummeted by 10312.55% in 2022.
  • SOPHiA GENETICS's Net Income (Quarter) stood at -$22.4 million in 2021, then soared by 35.4% to -$14.5 million in 2022, then tumbled by 66.1% to -$24.1 million in 2023, then surged by 37.0% to -$15.2 million in 2024, then dropped by 23.61% to -$18.7 million in 2025.
  • Its Net Income stands at -$18.7 million for Q3 2025, versus -$20.9 million for Q2 2025 and -$16.4 million for Q1 2025.